Eslicarbazepine Acetate
醋酸艾司利卡西平
Report date: 2025/05/21 20:00:31
NME
Base Information
Drug NameEslicarbazepine Acetate
Drug Alias Name +[12]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2009/04/20
Country/Territory +[28]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBial-Portela
China Registration ClassN/A
Develop Information
Active CompaniesBial - Portela C SaSumitomo Pharma America Inc
Inactive CompaniesBIAL-Portela & CA SA
Active Indications
Inactive Indications +[7]